Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's Disease

Phase 4TerminatedNCT00472706

Catharina Ziekenhuis Eindhoven65 enrolled

Overview

The purpose of this study is to identify the most optimal therapy for Bowen's disease: excision versus Photodynamic therapy.

The study is a randomized clinical trial in which two treatment options for Bowen's disease, excision and photodynamic therapy, are compared on recurrence rate, cosmesis en expenses.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Bowen's Disease

Interventions

excisionPROCEDURE

excision 3 mm margin

Photodynamic therapyPROCEDURE

Photodynamic therapy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years * Histological proven Bowen's disease on scalp, face, trunk, arms and legs * Informed Consent Exclusion Criteria: * Recurrent Bowen's disease * Anogenital or subungual Bowe's disease * Other skin malignancy in the same area * Porphyria

Outcomes

Primary Outcomes

recurrence rate

Time frame: two years

Secondary Outcomes

cosmetic outcome

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.